ew ayurvedic formulation regime in moderate COVID-19 patients

Not Applicable

Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Registration Number: CTRI/2021/07/034769

Lead Sponsor: Bonigi Anandaiah

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

Moderate COVID- 19 confirmed participants of age > 18 years, both sexes and willing to participate with consent.

WHO definition of the moderate case- Pneumonia with no signs of severe disease-Adolescent or adult with the presence of clinical features of dyspnea and or hypoxia, fever, cough, including SpO2 <94%( range 90-94%) on room air, Respiratory Rate more or equal to 24 per minute.

Exclusion Criteria

Those who are not willing to participate, patients with severe co- morbidities such as uncontrolled Diabetes, Liver disease, Renal disorders, uncontrolled Hypertension, pregnant and lactating women and severe COVID-19.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome: Efficacy can be evaluated by a reduction in inflammatory markers and time (No. of days) of reduction of detectable SARS-CoV2 viral RNA in the RT PCR assays from randomization. <br/ ><br>Secondary outcome: Time from randomization and administration of medicine to recovery is expected to be lesser in the test group <br/ ><br>Timepoint: Day0 to Day 4

Secondary Outcome Measures